GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Glenn Bauman discussing a prospective ...

[99mTc]Tc-iPSMA SPECT/CT as an alternative to PET imaging for decision making in prostate cancer patients. PREP registry: Key findings. Total (n=4135) Cohort 1 (n=255): BF within 3 months from RP and ...

Malaysia, meanwhile, is emerging as a prominent leader in adopting advanced prostate cancer treatments and diagnostics, including Prostate-Specific Membrane Antigen (PSMA) PET scans and ...

If you are tested for PSMA, doctors will administer a radioactive dye that binds to these antigens. Under a PET-CT scan, the dye lights up illuminating any trace of prostate cancer cells inside.

UK MHRA grants marketing authorization to Telix’s prostate cancer PET imaging agent, Illuccix: Melbourne, Australia Friday, February 14, 2025, 10:00 Hrs [IST] Telix, a commercia ...

PSMA-PET imaging[2] represents a major advancement in prostate cancer management, largely replacing conventional imaging ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...